[1] Rekvig OP.The dsDNA,anti-dsDNA antibody,and lupus nephritis:what we agree on,what must be done,and what the best strategy forward could be[J].Front Immunol,2019(10):1104.
[2] Infantino M,Grossi V,Benucci M,et al.The impact of biological treatments on the anti-dsDNA and anti-nucleosome tests[J].Lupus,2018,27(1):40-48.
[3] Rodriguez-Jimenez NA,Perez-Guerrero EE,Gamez-Nava JI,et al.Anti-nucleosome antibodies increase the risk of renal relapse in a prospective cohort of patients with clinically inactive systemic lupus erythematosus[J].Sci Rep,2020,10(1):12698.
[4] Yin Y,Wu X,Shan G,et al.Diagnostic value of serum anti-C1q antibodies in patients with lupus nephritis:a meta-analysis[J].Lupus,2012,21(10):1088-1097.
[5] Kianmehr N,Khoshmirsafa M,Shekarabi M,et al.High frequency of concurrent anti-C1q and anti-dsDNA but not anti-C3b antibodies in patients with Lupus Nephritis[J].J Immunoassay Immunochem,2021,42(4):406-423.
[6] Novak GV,Marques M,Balbi V,et al.Anti-RO/SSA and anti-La/SSB antibodies:association with mild lupus manifestations in 645 childhood-onset systemic lupus erythematosus[J].Autoimmun Rev,2017,16(2):132-135.
[7] Moroni G,Gatto M,Tamborini F,et al.Lack of EULAR/ERA-EDTA response at 1 year predicts poor long-term renal outcome in patients with lupus nephritis[J].Ann Rheum Dis,2020,79(8):1077-1083.
[8] Suttichet TB,Kittanamongkolchai W,Phromjeen C,et al.Urine TWEAK level as a biomarker for early response to treatment in active lupus nephritis:a prospective multicentre study[J].Lupus Sci Med,2019,6(1):e000298.
[9] Salem MN,Taha HA,Abd El-Fattah El-Feqi M,et al.Urinary TNF-like weak inducer of apoptosis (TWEAK) as a biomarker of lupus nephritis.TNF-ähnlicher schwacher Induktor von Apoptose (TWEAK) im Urin als Biomarker einer Lupusnephritis[J].Z Rheumatol,2018,77(1):71-77.
[10] Ma HY,Chen S,Cao WD,et al.Diagnostic value of TWEAK for predicting active lupus nephritis in patients with systemic lupus erythematosus:a systematic review and meta-analysis[J].Ren Fail,2021,43(1):20-31.
[11] Meena J,Thomas CC,Kumar J,et al.Biomarkers for prediction of acute kidney injury in pediatric patients:a systematic review and meta-analysis of diagnostic test accuracy studies[J].Pediatr Nephrol,2023,38(10):3241-3251.
[12] Gómez-Puerta JA,Ortiz-Reyes B,Urrego T,et al.Urinary neutrophil gelatinase-associated lipocalin and monocyte chemoattractant protein 1 as biomarkers for lupus nephritis in Colombian SLE patients[J].Lupus,2018,27(4):637-646.
[13] Elewa EA,El Tokhy MA,Fathy SE,et al.Predictive role of urinary neutrophil gelatinase-associated lipocalin in lupus nephritis[J].Lupus,2015,24(2):138-146.
[14] Hammad A,Mosaad Y,Elhanbly S,et al.Urinary neutrophil gelatinase-associated lipocalin as a marker of severe lupus nephritis in children[J].Lupus,2013,22(5):486-491.
[15] Gao Y,Wang B,Cao J,et al.Elevated urinary neutrophil gelatinase-associated lipocalin is a biomarker for lupus nephritis:a systematic review and meta-analysis[J].Biomed Res Int,2020(2020):2768326.
[16] Ding Y,Nie LM,Pang Y,et al.Composite urinary biomarkers to predict pathological tubulointerstitial lesions in lupus nephritis[J].Lupus,2018,27(11):1778-1789.
[17] Lee YH,Song GG.Urinary MCP-1 as a biomarker for lupus nephritis:a meta-analysis.MCP-1 im Urin als Biomarker bei Lupusnephritis:eine Metaanalyse[J].Z Rheumatol,2017,76(4):357-363.
[18] Singh RG,Usha,Rathore SS,et al.Urinary MCP-1 as diagnostic and prognostic marker in patients with lupus nephritis flare[J].Lupus,2012,21(11):1214-1218.
[19] Yang G,Guo N,Yin J,Wu J.Elevated soluble CD163 predicts renal function deterioration in lupus nephritis:a cohort study in Eastern China[J].J Int Med Res,2021,49(11):49963.
[20] Inthavong H,Vanarsa K,Castillo J,et al.Urinary CD163 is a marker of active kidney disease in childhood-onset lupus nephritis[J].Rheumatology (Oxford),2023,62(3):1335-1342.
[21] Singh S,Wu T,Vanarsa K,et al.Urine VCAM1 is a good indicator of renal pathology “activity index” in lupus nephritis[J].Clinical Immunology,2010 (135):81.
[22] Gasparin AA,de Andrade NPB,Hax V,et al.Urinary soluble VCAM-1 is a useful biomarker of disease activity and treatment response in lupus nephritis[J].BMC Rheumatol,2020,4(1):67.
[23] Abd-Elkareem MI,Al Tamimy HM,Khamis OA,et al.Increased urinary levels of the leukocyte adhesion molecules ICAM-1 and VCAM-1 in human lupus nephritis with advanced renal histological changes:preliminary findings[J].Clin Exp Nephrol,2010,14(6):548-557. |
2024, Vol. 30 
